Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00186446 · ClinicalTrials.gov registry record · Phase 4
Treatment of Nicotine Dependence and Acute Depression
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00186446: Completed Phase 4 study, sponsored by Stanford University.
NCT00186446 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00186446, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and feasibility of concurrent treatment of nicotine dependence (cigarette smoking) and acute depression. Participants who meet DSM-IV criteria for both nicotine dependence and acute major depression will be given pharmacological treatment for both disorders at the same time, along with a brief behavioral intervention for smoking cessation.
Interventions
- DRUG bupropion and smoking cessation behavioral intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-06 |
| Est. Completion | 2007-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00186446
The ClinicalTrials.gov registry entry for NCT00186446 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which bupropion and smoking cessation behavioral intervention is the first listed.
NCT00186446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00186446 about?
NCT00186446 is a clinical study titled "Treatment of Nicotine Dependence and Acute Depression". The purpose of this study is to assess the safety and feasibility of concurrent treatment of nicotine dependence (cigarette smoking) and acute depression. Participants who meet DSM-IV criteria for both nicotine dependence and acute major depression will be given pharmacological treatment for both di...
What is the current status of trial NCT00186446?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2004-06. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00186446?
The interventions under investigation include: bupropion and smoking cessation behavioral intervention (DRUG).
Who is sponsoring clinical trial NCT00186446?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.